CDKN2A and acute lymphoblastic leukemia: We also obtained evidence to suggest that the previously reported BCP-ALL risk variant in this region, rs3731217, is associated with BCP-ALL by regulating alternative splicing of CDKN2A, which we hypothesize is associated with differences in the translation of the p16 and p14ARF tumour suppressors encoded by this gene.